Speakers
  • home
  • Program
  • Speakers

Keynote Speakers

  • cv
    Keynote 1 Sunghoon Kim Seoul National University
    Korea
    Uncovering Novel Biomarkers for Next Generation Theranostics
  • Keynote 2 TBD
  • cv
    Keynote 3 Hans-Jürgen Wester Technical University of Munich
    Germany
    Radiohybrids: a groundbreaking new theranostics tracer concept
  • Keynote 4 TBD
  • cv
    Keynote 5 Richard Baum Central Clinic Bad Berka
    Germany
    Personalized Cancer Therapy: From Innovation to Implementation using Theranostics and Precision Oncology
  • cv
    Keynote 6 Dong Soo Lee Seoul National University
    Korea
    Brain Theranostics

Invited Speakers * Alphabetical Order: Last Name

  • cv
    Fani Bozkurt Hacettepe University
    Turkey
    Theranostics Efforts between Europe and Asia
  • cv
    Carlos Buchpiguel University of São Paulo
    Brazil
    Theranostics in Brazil
  • cv
    Weibo Cai University of Wisconsin–Madison
    USA
    Radiolabeled Nanomaterials: Ready for Clinical Translation
  • cv
    Juliano Julio Cerci University of São Paulo
    Brazil
    TBD
  • cv
    Cathy Cutler Brookhaven National Laboratory
    USA
    Alpha-emitters
  • cv
    Michael Hofman Peter MacCallum Cancer Centre
    Australia
    Practical Applications and Future Prospects of PRRT
  • cv
    Makoto Hosono Kindai University
    Japan
    ICRP Perspectives for Individualized Radionuclide Therapy
  • cv
    Andrei Iagaru Stanford University
    USA
    Gastrin-Releasing Peptide Receptors for Theranostics in Prostate Cancer
  • cv
    Jae Min Jeong Seoul National University
    Korea
    PSMA Urea-based Theranostic Probe
  • cv
    Keon Wook Kang Seoul National University
    Korea
    Theranostics in Korea
  • cv
    Seigo Kinuya Kanazawa University
    Japan
    Theranostics in Japan
  • cv
    Mark Konijnenberg Erasmus Medical Center
    The Netherlands
    Prospective Dosimetry Options for Alpha-emitter Targeted Therapy
  • cv
    Michael Kreissl University Hospital Magdeburg
    Germany
    Theranostics in Combination with Local Therapies
  • cv
    Yuji Kuge Hokkaido University
    Japan
    Hypoxia Imaging Probes for Theranostics
  • cv
    Jae Sung Lee Seoul National University
    Korea
    New Approaches to Fast Voxel-based Dosimetry
  • cv
    Seung-Hoon Lee Seoul National University
    Korea
    Therapeutic Nanoparticles awaiting for Theranostic Use
  • cv
    Yun-Sang Lee University Hospital Magdeburg
    Germany
    Platform Technology for Radionanotheranostics
  • cv
    Hongdi Li United Imaging Healthcare America, Inc.
    USA
    Phamacokinetic Modeling using Total Body PET
  • cv
    Beat Loeffler CLINAM - European Foundation for Clinical Nanomedicine
    Switzerland
    Nanomedicine: 11 Years of European Efforts
  • cv
    Josh Mailman NorCal CarciNet Community
    USA
    USA Experiences
  • cv
    Yoshiyuki Majima NPO PanCAN
    Japan
    Japanese Experiences
  • cv
    Jung-Joon Min Chonnam National University
    Korea
    Bacteria-based Theranostics
  • cv
    Greta Seng Peng Mok University of Macau
    Macau
    3D Voxel Dosimetry
  • cv
    Frank Rösch Institute of Nuclear Chemistry University Mainz
    Germany
    Kit-type Labelling Chemistry
  • cv
    Mike Sathekge University of Pretoria
    South Africa
    Implementation of Novel Theranostics in Africa
  • cv
    Michael K. Schultz University of Iowa Carver College of Medicine
    USA
    Peptide Receptor Targeted Theranostics for Cancer
  • cv
    Young Kee Shin Seoul National University
    Korea
    In Vitro to in Vivo Companion Diagnostics
  • cv
    Patricia Bernal Trujillo Universidad Javeriana
    Colombia
    Struggles of Theranostics in Latin America
  • cv
    Henry VanBrocklin The University of California, San Francisco (UCSF)
    USA
    Image Guided Therapy
  • cv
    Richard Wahl Washington University
    USA
    Future Perspectives of Theranostics in USA
  • cv
    Feng Wang Nanjing Medical University
    China
    Theranostics in China
  • cv
    Wolfgang Weber Technical University of Munich
    Germany
    Future Perspectives of Theranostics in Germany
  • cv
    Anna Wu University of California Los Angeles
    USA
    Antibody Theranostics
Organized by
Supported by